Home » Topics » BioWorld Science

BioWorld Science
RSS

Repurposing ritonavir as potential disease-modifying therapy for dystonia

Sep. 14, 2021

OncoPLEX yields promising results in animal models of GBM

Sep. 14, 2021

Twist Bioscience and Adicet collaborate on discovery of gamma delta T-cell cancer therapies

Sep. 14, 2021

ASCT2 is a prognostic marker in renal cell carcinoma

Sep. 14, 2021

ARN-75039 or ARN-75041 as potent arenavirus fusion inhibitors

Sep. 14, 2021

C-118P demonstrates antiproliferative activity in models of HCC

Sep. 14, 2021

ORAI1 behind the pathogenesis of pulmonary arterial hypertension

Sep. 14, 2021

Pre-existing chromosomal instability may predict response to paclitaxel

Sep. 14, 2021

ARN-19702 shows broad analgesic effect in animal models of pain

Sep. 13, 2021

Combined inhibition of RIPK1 and ferroptosis as potential therapeutic strategy for AKI

Sep. 13, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...